 |
SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...
It’s no surprise that Australia, like many countries, is facing a rise in cyber security threats with the latest Australian Cyber Security Center ...
I have 2 of the cutest housemates imaginable: pugs. Ernie is a 2 year old fawn with a slightly anxious but very sweet personality. Frank is a 6 mont...
When you’re looking to sell a house, there are a number of different things you need to take into account before you can do that. One of the main ...
Your perception of your business is unique. It has helped you build up your brand and establish your presence online, and above all, it has beco...
We all know that sales are the lifeblood of any business. Without them, revenue will dry up, and you will have to close your doors. It doesn't matte...
Mobile application development is a skill that you should take seriously. It's not the easiest task in the world, and it takes more than just techni...